The bioanalytical testing services market is witnessing substantial growth, primarily fueled by the increasing incidence of chronic and infectious diseases. The surge in demand for biopharmaceuticals and biologics is also contributing to market expansion. Moreover, pharmaceutical and biotechnology companies are actively broadening their R&D pipelines, especially in the development of biologics, biosimilars, and advanced therapies such as gene and cell therapies.New York, USA, Aug. 26, 2025 (GLOBRead More
